Contact US

GEDSA Releases November 2017 Guidance Document Supporting ISO 80369-3, ENFit®

GEDSA’s latest guid­ance docu­ment intro­duces several new clin­ical recom­men­da­tions that are key to successful ENFit tran­si­tions, including:

  • “For accu­rate enteral dosing of small doses, syringe sizes of 5 mL or smaller require an ENFit Low Dose Tip (LDT) Syringe design.”
  • “Transition connec­tors were only intended to be tempo­rary. To ensure compat­i­bility without the long-term use of adapters, GEDSA does not support the use of propri­etary connec­tors or any current or proposed male to female connec­tors.”
  • “Male ENFit connec­tors by design have a moat outside of the fluid path where fluid can build up. ENFit feeding tubes may be hard to keep clean. As with any feeding tube, proper tube main­te­nance is essen­tial.”

NeoMed’s line of ENFit solu­tions complies with all three recom­men­da­tions above by offering ENFit LDT syringes from 0.5 mL to 6 mL, an adapter-free system, and a cleaning tool used with our ENFit open floor hub feeding tube.

Click here for more ENFit Updates.

otc

NeoMed Unveils NeoConnect at Home OTC Reusable ENFit Syringe Line in the U.S.

May 30, 2019

NeoMed is excited to unveil NeoConnect® at Home™, a reusable port­folio of ENFit syringes that do not require a physician’s prescrip­tion…

Transitioning to the Safer ENFit Enteral Connector is Crucial to the Advancement of Patient Safety

August 13, 2018

Watch this video from GEDSA to learn why…

NeoMed 100 mL Syringe Now Characterized for Use in the Medfusion Enteral Ready Pump

May 25, 2018

NeoMed is pleased to announce it has added the 100 mL syringe to its port­folio of char­ac­ter­ized syringes for use in the Medfusion v6 3500 Enteral Ready Pump…
Medima

NeoMed and Medima Sp Partner to Provide an ENFit Enteral Pump Feeding Solution in Europe

December 14, 2018

NeoMed is excited to announce a part­ner­ship with Medima Sp to provide a complete enteral nutri­tion delivery solu­tion for NICUs and PICUs across Europe, parts of Asia, and the Middle East…